NLRX1 and neoplasm: Aberrant IL-6 and IL-18 levels both create a tumor microenvironment that is favorable for the tumor cells by promoting survival and establishing an immunosuppressive environment, suggesting that NLRX1 may protect against pancreatic tumors through regulating inflammation and inflammatory cytokines (57).